Long Non-Coding RNAs as Key Modulators of Pancreatic β-Cell Mass and Function

Area of Science:

• Endocrinology
• Molecular Biology
• Genetics

Background:

• Diabetes mellitus etiology remains incompletely understood, with limited treatment options.
• Most diabetes susceptibility loci are in non-coding genomic regions.
• Non-coding RNAs, particularly long non-coding RNAs (lncRNAs), are increasingly recognized for their role in beta-cell biology.

Purpose of the Study:

• To review the critical roles of lncRNAs in maintaining pancreatic beta-cell mass and function.
• To explore the involvement of lncRNAs in the pathogenesis of type 1 (T1D) and type 2 (T2D) diabetes.
• To discuss the potential of lncRNAs as therapeutic targets for diabetes.

Main Methods:

• Literature review of studies on lncRNAs and beta-cell biology.
• Analysis of lncRNA involvement in beta-cell proliferation, apoptosis, and gene regulation.
• Synthesis of current knowledge on lncRNAs in diabetes pathogenesis.

Main Results:

• lncRNAs are vital for beta-cell development, proliferation, and compensation during hyperglycemia.
• Specific lncRNAs (e.g., TUG-1, MEG3) influence beta-cell apoptosis and function.
• lncRNAs regulate key beta-cell transcription factors, impacting overall beta-cell function.

Conclusions:

• lncRNAs are key regulators of beta-cell function and mass, crucial for maintaining glucose homeostasis.
• Dysregulation of lncRNAs contributes to diabetes development.
• Targeting lncRNAs may offer novel therapeutic strategies for managing diabetes mellitus.